|1.||Tseng, Sheng-Hong: 7 articles (01/2011 - 02/2009)|
|2.||Chen, Yun: 7 articles (01/2011 - 02/2009)|
|3.||Li, Wenhua: 5 articles (05/2015 - 09/2011)|
|4.||Chen, Jin-Cherng: 5 articles (01/2014 - 02/2009)|
|5.||Liu, Baorui: 5 articles (02/2012 - 10/2007)|
|6.||Cheng, Jian: 5 articles (01/2011 - 02/2005)|
|7.||Chen, Bao-An: 5 articles (11/2008 - 02/2005)|
|8.||Gao, Feng: 4 articles (01/2011 - 02/2005)|
|9.||Liu, Xin: 3 articles (05/2015 - 01/2015)|
|10.||Li, Xiaolin: 3 articles (01/2014 - 08/2010)|
09/01/1989 - "The genotoxicity of tetrandrine, a drug potentially useful for the treatment of silicosis, was studied using the micronucleus and the sister-chromatid exchange (SCE) assay systems. "
01/01/1988 - "The effects of tetrandrine, a benzylisoquinoline alkaloid useful in the treatment of silicosis, on a broad range of human neutrophil activities was examined in vitro. "
08/01/1986 - "Tetrandrine is a plant alkaloid useful in the treatment of silicosis. "
09/01/1995 - "A biochemical study on combined treatment of experimental silicosis with tetradrine-PVNO and tetradrine-QOHP in rats."
04/01/1983 - "[Preliminary study of the mechanism of silicosis therapy by tetrandrine]."
12/01/2002 - "To evaluate the potential clinical efficacy of tetrandrine for cancer therapy, more mechanism-based pharmacological, pharmacokinetic, and pharmacodynamic studies are required."
05/01/2014 - "Our present study showed that tetrandrine can dramatically enhance the anti- cancer effect induced by As2O3. "
05/01/2014 - "The present study was designed to assess whether the combination of As2O3 and tetrandrine could generate a more powerful anti-cancer effect. "
01/01/2014 - "Earlier studies have demonstrated the promising antitumor effect of tetrandrine (Tet) against a series of cancers. "
04/01/2008 - "Recent studies have shown that the multidrug resistance of tumor cells can be reversed by tetrandrine by potentiating the cytotoxicity of chemotherapeutic agents. "
04/01/2004 - "In the present study, we examined the apoptosis-inducing effect of tetrandrine on activated hepatic stellate cells, as the therapeutic goal in hepatic fibrosis is to eliminate the activated hepatic stellate cells by apoptosis. "
06/15/2015 - "Tetrandrine reverses human cardiac myofibroblast activation and myocardial fibrosis."
02/01/2010 - "Tetrandrine also inhibited fibrosis and attenuated the inflammatory response. "
01/01/2007 - "Tetrandrine exerts antifibrotic effects in both HSC-T6 cells and in rats with DMN-induced fibrosis."
04/01/2004 - "In conclusion, our results demonstrate that tetrandrine induces apoptosis of T-HSC/Cl-6 cells, and these results should contribute to the development of new agents for the treatment of hepatic fibrosis."
08/01/1997 - "However, the potential role of tetrandrine as a therapeutic agent in portal hypertension has yet to be explored. "
11/01/1995 - "It is suggested that tetrandrine should be more effective for cirrhotic patients with portal hypertension in preventing recurrent variceal bleeding."
01/01/2004 - "Tetrandrine can significantly ameliorate cirrhosis and portal hypertension."
03/01/1998 - "Tetrandrine is a type of calcium channel blocker recently reported to reduce portal hypertension. "
01/01/2004 - "Tetrandrine ameliorates cirrhosis and portal hypertension by inhibiting nitric oxide in cirrhotic rats."
|5.||Hepatocellular Carcinoma (Hepatoma)
09/01/2003 - "These data suggest that tetrandrine may constitute a plausible therapeutic for hepatocellular carcinoma."
06/01/2013 - "In this study, we investigated the effects of tetrandrine in hepatocellular carcinoma (HCC) cells. "
09/15/2011 - "In our study, we investigated the effects of tetrandrine on the human hepatocellular carcinoma (HCC) in vitro and in vivo. "
07/01/2002 - "In the present study, we examined the antiproliferative and apoptosis-inducing activity of tetrandrine in HepG2 cells, a human hepatoma cell line. "
05/01/2015 - "Tetrandrine induced apoptosis or, at low concentrations, autophagy of human hepatocellular carcinoma cells. "
|3.||NF-kappa B (NF-kB)
|4.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|5.||Hydroxyproline (4 Hydroxyproline)
|10.||Hyaluronic Acid (Hyaluronan)
|1.||Heterologous Transplantation (Xenotransplantation)
|2.||Drug Therapy (Chemotherapy)
|5.||Transplantation (Transplant Recipients)